Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Original language | English |
---|---|
Article number | A102 |
Journal | American Journal of Respiratory and Critical Care Medicine |
Volume | 199 |
Issue number | A2438 |
ISSN | 1073-449X |
DOIs | |
Publication status | Published - 2019 |
ID: 218435956